Following incubation, media was discarded and the formazan crystals were solubilized by adding 200 μL DMSO and the absorbance measured at A560 nm. The percentage toxicity was calculated as A phage library displaying random 7-residue peptides was

panned against (His)6-DevR protein. Five rounds of panning were EPZ015666 mw performed (three rounds with (His)6-DevR immobilized on Ni2+ NTA magnetic agarose beads and two rounds with (His)6-DevR coated on a well in a polystyrene ELISA plate) to select DevR binders and to exclude bead and plastic binding phages. Selective enrichment of DevR binding phages was achieved using this approach as demonstrated by approximately fourfold more efficient binding to DevR of the phages derived from the fifth round of panning compared to the unpanned phage pool. Furthermore, the enriched phage did not bind to either BSA or plastic (Fig. 1a). A total of 194 phage clones from DevS~P and glycine elutions from the final round of panning were individually amplified and screened by ELISA to select DevR binding phages. Nineteen phage clones were selected for sequencing based on their binding selectivity to DevR (not shown). The sequence ‘TLHLHHL’ was repeated 15 times and a 7-mer peptide, DevRS1, bearing this sequence was synthesized and further characterized. In an ELISA performed with purified full-length N-terminal-tagged

glutathione-S-transferase [GST]-DevR (Bagchi et al., 2005) and its individual Ruxolitinib manufacturer N- and C-terminal domains, DevRS1 sequence displaying phage clone

G43 bound relatively more efficiently to the DevR C-terminal domain (DevRC, containing 144–217 amino acids of DevR expressed with a N-terminal tag of GST) as compared to the N-terminal domain of DevR (DevRN, containing 1–144 amino acids of DevR expressed with a N-terminal GST tag) and poorly to GST alone or to BSA or plastic (Fig. 1b). The binding specificity of DevRS1 was confirmed by a competition ELISA wherein the peptide DevRS1 inhibited the binding of TLHLHHL-displaying phage (G43) to (His)6-DevR but not of nonspecific binder phage (Fig. 1c). The effect of DevRS1 peptide on gene expression and viability of M. tb was examined next. Exposure to DevRS1 peptide at 5 mM concentration resulted in ~ 55–60% inhibition of Rv3134c promoter activity (a DevR-regulated N-acetylglucosamine-1-phosphate transferase promoter, Fig. 2a, black bars) with respect to DMSO control under both aerobic and hypoxic conditions. The observed inhibition of promoter activity in the aerobic set up is ascribed to the development of hypoxia in standing cultures (Chauhan & Tyagi, 2008a). The activity of the constitutively expressed sigA promoter was not affected under identical conditions (Fig. 2a), indicating the target specificity of the peptide. It is expected that inhibition of Rv3134c promoter activity would be associated with the inhibition of other regulon promoters as observed by Gupta et al.